Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Germany’s Complement Bets On Gene Therapy For Geographic Atrophy

As Series A Raises €72m

Apr 17 2023

• By Kevin Grogan

Rafiq Hasan — Rafiq Hasan • Source: Complement Therapeutics

Related Content

Apellis Set For Blockbuster Success With Syfovre, The First Approved Geographic Atrophy Drug

Feb 20 2023

Iveric Bio Building Ophthalmology Commercial Team Ahead Of First Launch

Feb 13 2023

Related Companies

Complement Therapeutics, Ltd.

Apellis Pharmaceuticals, Inc.

Iveric Bio, Inc.

Bayer AG

Regeneron Pharmaceuticals, Inc.

Novartis AG

Additional Topics

Commercial Financing Gene Therapy Strategy StartUps and SMEs Ophthalmic BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window